An overview of the molecular resistance mechanisms of antimycobacterial drugs Antimikobakteriyel ilaçların moleküler direnç mekanizmalarına genel bir bakış


Creative Commons License

ÇİFTÇİ E., SATANA D.

Turk Hijyen ve Deneysel Biyoloji Dergisi, cilt.82, sa.1, ss.197-206, 2025 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 82 Sayı: 1
  • Basım Tarihi: 2025
  • Doi Numarası: 10.5505/turkhijyen.2025.15045
  • Dergi Adı: Turk Hijyen ve Deneysel Biyoloji Dergisi
  • Derginin Tarandığı İndeksler: Scopus, Academic Search Premier, CAB Abstracts, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.197-206
  • Anahtar Kelimeler: drug resistance, duyarlılık, ilaç direnci, mikobakteri, mycobacteria, susceptibility, Tuberculosis, Tüberküloz
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • İstanbul Üniversitesi Adresli: Evet

Özet

Tuberculosis, a contagious and lethal disease, continues to be one of the most significant health problems worldwide. Currently, treatment with appropriate doses and combinations is effective; however, resistance to medication can develop due to factors such as low dosage, incorrect combinations, and patient abandoning treatment. As a result, resistance to a single drug may occur, as well as strains resistant to more than one drug. Resistance in bacteria occurs through gene transfer. However, mycobacteria develop resistance through spontaneous point mutations rather than gene transfer. Understanding the effect area of known drugs on mycobacteria is crucial for determining drug combinations and compatibility in treatment. The long duration of mycobacterial susceptibility tests delays both the initiation of treatment and the identification of resistance. Rapid molecular susceptibility tests have been developed to address this issue. Molecular drug susceptibility tests are rapid methods that can determine resistance quickly, detect the presence or absence of mutations in the relevant gene region, and exposes the resistance mechanism. However, molecular tests may sometimes result in cases where phenotypic resistance is not reflected despite genotypic resistance appearing to be present. Additionally, strains that are determined to be susceptible by molecular tests may exhibit phenotypic resistance. Given the potential challenges such as the long duration of tuberculosis treatment, patient abandonment, and disease relapse, the use of molecular tests provides significant benefits to clinicians. However, it is essential to verify the obtained results with classical antibiotic susceptibility tests. In conclusion, it is believed that the existence of new technologies and the use of classical drug susceptibility tests will allow for the understanding of drug effect-resistance mechanisms, influence the development of next-generation drugs in tuberculosis treatment, and enable the minimization of resistance development against new drugs.